ANGPTL3 (N-term), 82-114 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-ANGPTL3 (N-term), 82-114 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | ANGPTL3 (N-term), 82-114 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse |
| Isotype | n/a |
| Format | purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 2 |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This ANGPTL3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 82-114 amino acids from the N-terminal region of human ANGPTL3. ANGPTL3 is a member of the angiopoietin-like family of secreted factors. It is predominantly expressed in the liver, and has the characteristic structure of angiopoietins, consisting of a signal peptide, N-terminal coiled-coil domain and the C-terminal fibrinogen (FBN)-like domain. The FBN-like domain in angiopoietin-like 3 protein was shown to bind alpha-5/beta-3 integrins, and this binding induced endothelial cell adhesion and migration. This protein may also play a role in the regulation of angiogenesis. |
| Immunogen | n/a |
| Other Names | [Angiopoietin-related protein 3; Angiopoietin-5; ANG-5; Angiopoietin-like protein 3; ANGPTL3; ANGPT5] |
| Gene, Accession # | [ANGPTL3], Gene ID: 27329, NCBI: NP_055310.1, UniProt: Q9Y5C1 |
| Catalog # | MBS9214666 |
| Price | $165, $370 |
| Order / More Info | ANGPTL3 (N-term), 82-114 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Shan,L., J. Biol. Chem. 284 (3), 1419-1424 (2009) Shimamura,M., Biochem. Biophys. Res. Commun. 301 (2), 604-609 (2003) |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies